chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Joint range of motion decreased, Pain in extremity
Clinical narrative: Continuous severe pain in arm; Severe pain in shoulder; Joint mobility restriction; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 29Mar2021 at 11:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history and Concomitant medications were not reported. The patient had known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 08Mar2021 at 10:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021, the patient experienced continuous severe pain in arm, severe pain in shoulder and joint mobility restriction. The events resulted in emergency room/department or urgent care visit. Therapeutic measures were taken as a result of events and included treatment with unspecified medication (shot). The clinical outcome of the event continuous severe pain in arm, severe pain in shoulder and joint mobility restriction was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Joint stiffness, Pain in extremity
Clinical narrative: Continuous severe pain in arm; Severe pain in shoulder; Joint mobility restriction; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 29Mar2021 at 11:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history and Concomitant medications were not reported. The patient had known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 08Mar2021 at 10:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021, the patient experienced continuous severe pain in arm, severe pain in shoulder and joint mobility restriction. The events resulted in emergency room/department or urgent care visit. Therapeutic measures were taken as a result of events and included treatment with unspecified medication (shot). The clinical outcome of the event continuous severe pain in arm, severe pain in shoulder and joint mobility restriction was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Rash that was on neck, collar bone, bottom of head hair line, under arms, my groin area, sides, stomach, back , butt, breast.; Felt slightly nauseous; Felt slightly nauseous and light headed but did not throw up.; Rash was itchy and raised.; Rash was itchy and raised.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0161) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluticasone propionate (FLOVENT HFA), lisdexamfetamine mesilate (VYVANSE) and 365 prenatal vitamin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 00:00, the patient experienced rash that was on neck, collar bone, bottom of head hair line, under arms, groin area, sides, stomach, back, butt and breast, the patient felt slightly nauseous and light headed but did not throw up, rash was itchy and raised. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with Benadryl pill, hydrocortisone cream on rash area and teledoc appointment recommended treatment with xyzal antihistamine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash that was on neck, collar bone, bottom of head hair line, under arms, groin area, sides, stomach, back, butt and breast, felt slightly nauseous and light headed but did not throw up, rash was itchy and raised was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Nausea, Rash, Rash papular, Rash pruritic
Clinical narrative: Rash that was on neck, collar bone, bottom of head hair line, under arms, my groin area, sides, stomach, back , butt, breast.; Felt slightly nauseous; Felt slightly nauseous and light headed but did not throw up.; Rash was itchy and raised.; Rash was itchy and raised.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0161) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluticasone propionate (FLOVENT HFA), lisdexamfetamine mesilate (VYVANSE) and 365 prenatal vitamin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 00:00, the patient experienced rash that was on neck, collar bone, bottom of head hair line, under arms, groin area, sides, stomach, back, butt and breast, the patient felt slightly nauseous and light headed but did not throw up, rash was itchy and raised. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with Benadryl pill, hydrocortisone cream on rash area and teledoc appointment recommended treatment with xyzal antihistamine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash that was on neck, collar bone, bottom of head hair line, under arms, groin area, sides, stomach, back, butt and breast, felt slightly nauseous and light headed but did not throw up, rash was itchy and raised was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Impaired work ability, Migraine, Nausea, SARS-CoV-2 test, Tension headache
Clinical narrative: diagnosed as migraine; Unable to work; Severe headache; Nausea; Lightheadedness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 12Apr2021 at 10:45 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no allergies to medications, food, or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and metoprolol succinate (TOPROL XL); both for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 06:00, next day to vaccination, severe headache started with nausea and lightheadedness. By 16Apr2021, patient was unable to work. The patient went to ER and was diagnosed as having migraine and had no blood work or tests done. The patient stated he would see family physician the day after. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included nasal swab for COVID-19 on 18Apr2021 and the result was pending at the time of this report. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as result of events severe headache, nausea, lightheadedness and migraine and included treatment with intravenous fluids (IV fluids) and migraine cocktail - Toradol. The clinical outcome of the events severe headache with nausea and lightheadedness which was diagnosed as migraine and unable to work was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Loss of personal independence in daily activities, Migraine, Nausea
Clinical narrative: diagnosed as migraine; Unable to work; Severe headache; Nausea; Lightheadedness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 12Apr2021 at 10:45 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no allergies to medications, food, or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and metoprolol succinate (TOPROL XL); both for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 06:00, next day to vaccination, severe headache started with nausea and lightheadedness. By 16Apr2021, patient was unable to work. The patient went to ER and was diagnosed as having migraine and had no blood work or tests done. The patient stated he would see family physician the day after. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included nasal swab for COVID-19 on 18Apr2021 and the result was pending at the time of this report. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as result of events severe headache, nausea, lightheadedness and migraine and included treatment with intravenous fluids (IV fluids) and migraine cocktail - Toradol. The clinical outcome of the events severe headache with nausea and lightheadedness which was diagnosed as migraine and unable to work was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: diagnosed as migraine; Unable to work; Severe headache; Nausea; Lightheadedness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 12Apr2021 at 10:45 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no allergies to medications, food, or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and metoprolol succinate (TOPROL XL); both for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 06:00, next day to vaccination, severe headache started with nausea and lightheadedness. By 16Apr2021, patient was unable to work. The patient went to ER and was diagnosed as having migraine and had no blood work or tests done. The patient stated he would see family physician the day after. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included nasal swab for COVID-19 on 18Apr2021 and the result was pending at the time of this report. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as result of events severe headache, nausea, lightheadedness and migraine and included treatment with intravenous fluids (IV fluids) and migraine cocktail - Toradol. The clinical outcome of the events severe headache with nausea and lightheadedness which was diagnosed as migraine and unable to work was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough, Dyspnoea, Insomnia, Nausea
Clinical narrative: chills; a fever of 102.4; body aches; achy; nauseous; short of breath; cough every time I talked; insomnia; This is a spontaneous report received from a contactable consumer or other non hcp. A 50-years-old female patient received 2nd dose of bnt162b2 (Pfizer covid19 vaccine,Batch/Lot Number: EN6207), via an unspecified route of administration ,at the age of 50 years old,on 08Apr2021 16:30 as Dose 2,single for covid-19 immunization.Medical history included contrast media allergy, dermatitis contact and allergy to metals, gluten sensitivity, bundle branch block left  also have mitral valve and left bundle branch block, mitral valve disease from an unknown date and unknown if ongoing also have mitral valve and left bundle branch block. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN) taken for an unspecified indication, start and stop date were not reported; colecalciferol (Vitamin D )cyanocobalamin (VIT B12) taken for an unspecified indication, start and stop date were not reported.The patient previously took bnt162b2 for covid-19 immunization,on 21Mar2021,03:45.The patient experienced body aches on 09Apr2021 11:00, achy,nauseous,chills, a fever of 102.4 on 09Apr2021 19:00, short of breath on 09Apr2021,cough every time she talked on 09Apr2021 and insomnia on 09Apr2021.The patient underwent lab tests and procedures which included body temperature: 102.4 on 09Apr2021.Therapeutic measures were taken as a result of short of breath and cough every time.The patient had not received other vaccine in 4 weeks.The outcome of the events was recovered.The patient was not tested for covid prior vaccination and not tested for covid post vaccination.  No follow up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: chills; a fever of 102.4; body aches; achy; nauseous; short of breath; cough every time I talked; insomnia; This is a spontaneous report received from a contactable consumer or other non hcp. A 50-years-old female patient received 2nd dose of bnt162b2 (Pfizer covid19 vaccine,Batch/Lot Number: EN6207), via an unspecified route of administration ,at the age of 50 years old,on 08Apr2021 16:30 as Dose 2,single for covid-19 immunization.Medical history included contrast media allergy, dermatitis contact and allergy to metals, gluten sensitivity, bundle branch block left  also have mitral valve and left bundle branch block, mitral valve disease from an unknown date and unknown if ongoing also have mitral valve and left bundle branch block. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN) taken for an unspecified indication, start and stop date were not reported; colecalciferol (Vitamin D )cyanocobalamin (VIT B12) taken for an unspecified indication, start and stop date were not reported.The patient previously took bnt162b2 for covid-19 immunization,on 21Mar2021,03:45.The patient experienced body aches on 09Apr2021 11:00, achy,nauseous,chills, a fever of 102.4 on 09Apr2021 19:00, short of breath on 09Apr2021,cough every time she talked on 09Apr2021 and insomnia on 09Apr2021.The patient underwent lab tests and procedures which included body temperature: 102.4 on 09Apr2021.Therapeutic measures were taken as a result of short of breath and cough every time.The patient had not received other vaccine in 4 weeks.The outcome of the events was recovered.The patient was not tested for covid prior vaccination and not tested for covid post vaccination.  No follow up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Cough, Dyspnoea, Insomnia
Clinical narrative: chills; a fever of 102.4; body aches; achy; nauseous; short of breath; cough every time I talked; insomnia; This is a spontaneous report received from a contactable consumer or other non hcp. A 50-years-old female patient received 2nd dose of bnt162b2 (Pfizer covid19 vaccine,Batch/Lot Number: EN6207), via an unspecified route of administration ,at the age of 50 years old,on 08Apr2021 16:30 as Dose 2,single for covid-19 immunization.Medical history included contrast media allergy, dermatitis contact and allergy to metals, gluten sensitivity, bundle branch block left  also have mitral valve and left bundle branch block, mitral valve disease from an unknown date and unknown if ongoing also have mitral valve and left bundle branch block. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN) taken for an unspecified indication, start and stop date were not reported; colecalciferol (Vitamin D )cyanocobalamin (VIT B12) taken for an unspecified indication, start and stop date were not reported.The patient previously took bnt162b2 for covid-19 immunization,on 21Mar2021,03:45.The patient experienced body aches on 09Apr2021 11:00, achy,nauseous,chills, a fever of 102.4 on 09Apr2021 19:00, short of breath on 09Apr2021,cough every time she talked on 09Apr2021 and insomnia on 09Apr2021.The patient underwent lab tests and procedures which included body temperature: 102.4 on 09Apr2021.Therapeutic measures were taken as a result of short of breath and cough every time.The patient had not received other vaccine in 4 weeks.The outcome of the events was recovered.The patient was not tested for covid prior vaccination and not tested for covid post vaccination.  No follow up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Pyrexia
Clinical narrative: chills; a fever of 102.4; body aches; achy; nauseous; short of breath; cough every time I talked; insomnia; This is a spontaneous report received from a contactable consumer or other non hcp. A 50-years-old female patient received 2nd dose of bnt162b2 (Pfizer covid19 vaccine,Batch/Lot Number: EN6207), via an unspecified route of administration ,at the age of 50 years old,on 08Apr2021 16:30 as Dose 2,single for covid-19 immunization.Medical history included contrast media allergy, dermatitis contact and allergy to metals, gluten sensitivity, bundle branch block left  also have mitral valve and left bundle branch block, mitral valve disease from an unknown date and unknown if ongoing also have mitral valve and left bundle branch block. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN) taken for an unspecified indication, start and stop date were not reported; colecalciferol (Vitamin D )cyanocobalamin (VIT B12) taken for an unspecified indication, start and stop date were not reported.The patient previously took bnt162b2 for covid-19 immunization,on 21Mar2021,03:45.The patient experienced body aches on 09Apr2021 11:00, achy,nauseous,chills, a fever of 102.4 on 09Apr2021 19:00, short of breath on 09Apr2021,cough every time she talked on 09Apr2021 and insomnia on 09Apr2021.The patient underwent lab tests and procedures which included body temperature: 102.4 on 09Apr2021.Therapeutic measures were taken as a result of short of breath and cough every time.The patient had not received other vaccine in 4 weeks.The outcome of the events was recovered.The patient was not tested for covid prior vaccination and not tested for covid post vaccination.  No follow up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Computerised tomogram head, Hyperacusis, Neuralgia, Pain
Clinical narrative: The left side of face is numb; tingling from the corner of mouth to the top of my cheek.; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;  Lot Number: Ep7533) via an unspecified route of administration in the left arm on 14Apr2021 at 09:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient was allergic to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paracetamol (TYLENOL) for an unknown indication and on occasion. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 18:00, the patient experienced left side of her face was numb and tingling from the corner of her mouth to the top of her cheek. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events left side of her face was numb and tingling from the corner of her mouth to the top of her cheek was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia oral
Clinical narrative: The left side of face is numb; tingling from the corner of mouth to the top of my cheek.; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;  Lot Number: Ep7533) via an unspecified route of administration in the left arm on 14Apr2021 at 09:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient was allergic to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paracetamol (TYLENOL) for an unknown indication and on occasion. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 18:00, the patient experienced left side of her face was numb and tingling from the corner of her mouth to the top of her cheek. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events left side of her face was numb and tingling from the corner of her mouth to the top of her cheek was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Pain in extremity
Clinical narrative: Abdominal pain; muscle pain; ankle pain; armpit pain; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 10:30 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Apr2021, the patient experienced abdominal pain, muscle pain, ankle pain and armpit pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events abdominal pain, muscle pain, ankle pain and armpit pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events abdominal pain, muscle pain, ankle pain and armpit pain was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Arthralgia, Axillary pain, Myalgia
Clinical narrative: Abdominal pain; muscle pain; ankle pain; armpit pain; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 10:30 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Apr2021, the patient experienced abdominal pain, muscle pain, ankle pain and armpit pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events abdominal pain, muscle pain, ankle pain and armpit pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events abdominal pain, muscle pain, ankle pain and armpit pain was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Joint contracture, Paraesthesia, Throat tightness, Urinary incontinence
Clinical narrative: right hand and fingers severely contracted; had NO control over my bladder/urine flowed down before I could get to the toilet; Throat began closing and lasted 20 minutes; dry skin spots on my torso and hip areas - especially on my right side; This is a spontaneous report from a contactable consumer (Patient). A 69-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0150), dose 1 via an unspecified route of administration, administered in Arm Right on 09Apr2021 at 14:15 (at the age of 69 year) as dose 1, single for COVID-19 immunisation at other facility. Medical history included sleep apnea, hypertension, arthritis. Patient had COVID prior vaccination. Patient had known allergies to any meds that contain ace inhibitors/tarka. No other vaccine in four weeks. No COVID tested post vaccination: Concomitant medication(s) included amlodipine besylate (AMLODIPINE BESYLATE); etodolac (ETODOLAC); paracetamol (TYLENOL). Patient previously took Tarka and experienced drug allergy. On 09Apr2021 at 14:15, patient experienced throat began closing and lasted 20 minutes. On 10Apr2021, next morning patient awakened with right hand and fingers severely contracted, and patient forced hand and fingers to open and close several times to return to normal position. All day patient had no control over bladder. Urine flowed down before patient could get to the toilet. On an unspecified date in Apr2021, a week later patient developed dry skin spots on torso and hip areas- especially on right side. AE did not result in physician office and emergency room. It was reported that no therapeutic measures were taken for the events experienced. The outcome of event throat tightness was recovered on 09Apr2021 and for all rest events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dry skin, Joint contracture, Throat tightness, Urinary incontinence
Clinical narrative: right hand and fingers severely contracted; had NO control over my bladder/urine flowed down before I could get to the toilet; Throat began closing and lasted 20 minutes; dry skin spots on my torso and hip areas - especially on my right side; This is a spontaneous report from a contactable consumer (Patient). A 69-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0150), dose 1 via an unspecified route of administration, administered in Arm Right on 09Apr2021 at 14:15 (at the age of 69 year) as dose 1, single for COVID-19 immunisation at other facility. Medical history included sleep apnea, hypertension, arthritis. Patient had COVID prior vaccination. Patient had known allergies to any meds that contain ace inhibitors/tarka. No other vaccine in four weeks. No COVID tested post vaccination: Concomitant medication(s) included amlodipine besylate (AMLODIPINE BESYLATE); etodolac (ETODOLAC); paracetamol (TYLENOL). Patient previously took Tarka and experienced drug allergy. On 09Apr2021 at 14:15, patient experienced throat began closing and lasted 20 minutes. On 10Apr2021, next morning patient awakened with right hand and fingers severely contracted, and patient forced hand and fingers to open and close several times to return to normal position. All day patient had no control over bladder. Urine flowed down before patient could get to the toilet. On an unspecified date in Apr2021, a week later patient developed dry skin spots on torso and hip areas- especially on right side. AE did not result in physician office and emergency room. It was reported that no therapeutic measures were taken for the events experienced. The outcome of event throat tightness was recovered on 09Apr2021 and for all rest events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Appendicitis
Clinical narrative: They told me my Appendix will have to be removed; I thought I caught a stomach bug from my coworker; Sharp pain; This is a spontaneous report from a contactable consumer (patient) via . This 34-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration in the right arm on 01Apr2021 (at 34-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history or concomitant medications. The patient had no known allergies, had not been diagnosed with COVID prior to vaccination and had not received any other vaccines in four weeks. The patient reported he woke up on Friday morning, 09Apr2021 at 05:30, with a sharp pain. He though he caught a stomach bug from a coworker. The patient stated he "let it play out," and the next morning was still in pain. The patient went to the emergency room and was told his appendix would have to be removed. The patient reported his appendix was removed. The clinical outcomes of the events were recovering. On 10Apr2021 the patient was tested via nasal swab for COVID which was negative.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Appendix disorder, Gastric disorder, Pain, SARS-CoV-2 test
Clinical narrative: They told me my Appendix will have to be removed; I thought I caught a stomach bug from my coworker; Sharp pain; This is a spontaneous report from a contactable consumer (patient) via . This 34-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration in the right arm on 01Apr2021 (at 34-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history or concomitant medications. The patient had no known allergies, had not been diagnosed with COVID prior to vaccination and had not received any other vaccines in four weeks. The patient reported he woke up on Friday morning, 09Apr2021 at 05:30, with a sharp pain. He though he caught a stomach bug from a coworker. The patient stated he "let it play out," and the next morning was still in pain. The patient went to the emergency room and was told his appendix would have to be removed. The patient reported his appendix was removed. The clinical outcomes of the events were recovering. On 10Apr2021 the patient was tested via nasal swab for COVID which was negative.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Disturbance in attention, Dizziness, Hypertension
Clinical narrative: blood pressure 170/100; dizzy; Unfocused; Felt like I never slept; This is a spontaneous report from contactable consumer (patient herself). A 57-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: ER8732, expiry date: unknown) via unspecified route of administration, in left arm on 01Apr2021 10:30 (age at vaccination: 57-years) as dose 1, single for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Patients medical history included Lyme disease, bartonella, tooth bone graft infection, covid-19 from an unspecified date and unknown if ongoing. Past drug included known allergies from penicillin. Concomitant medications reported were Trazadone, Adderall, Wellbutrin, Flonase, (taken in two weeks), for unspecified indication, start and stop date unknown. Patient did not any other vaccines in four weeks. Patient had not been tested for covid since the vaccination. On 03Apr2021, patient experienced dizzy, unfocused, felt like i never slept, blood pressure 170/100 for 2 weeks. The patient underwent lab test blood blood pressure measurement, with results 170/100, (blood pressure 170/100 for 2 weeks) on an unspecified date. Treatment was given with lisinopryl 10mg for the adverse events. There was doctor or other healthcare professional office/clinic visit due to the events. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure abnormal, Blood pressure measurement, Disturbance in attention, Dizziness, Somnolence
Clinical narrative: blood pressure 170/100; dizzy; Unfocused; Felt like I never slept; This is a spontaneous report from contactable consumer (patient herself). A 57-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: ER8732, expiry date: unknown) via unspecified route of administration, in left arm on 01Apr2021 10:30 (age at vaccination: 57-years) as dose 1, single for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Patients medical history included Lyme disease, bartonella, tooth bone graft infection, covid-19 from an unspecified date and unknown if ongoing. Past drug included known allergies from penicillin. Concomitant medications reported were Trazadone, Adderall, Wellbutrin, Flonase, (taken in two weeks), for unspecified indication, start and stop date unknown. Patient did not any other vaccines in four weeks. Patient had not been tested for covid since the vaccination. On 03Apr2021, patient experienced dizzy, unfocused, felt like i never slept, blood pressure 170/100 for 2 weeks. The patient underwent lab test blood blood pressure measurement, with results 170/100, (blood pressure 170/100 for 2 weeks) on an unspecified date. Treatment was given with lisinopryl 10mg for the adverse events. There was doctor or other healthcare professional office/clinic visit due to the events. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chills, Dizziness, Gait disturbance, Headache
Clinical narrative: facial numbing; facial numbing and tingling; regular flu-like symptoms,; extreme nausea; ongoing dizziness; weakness; fatigue; constant tinnitus; ongoing vertigo; headaches; constant sinus pressure; funny taste in mouth,; urine smells different; heart palpitations; racing heart beat; anxiety; This is a spontaneous report from a contactable consumer (patient). A 41-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for Injection, Lot number: unknown) via an unspecified route of administration, administered in arm left on 04Apr2021 at 13:00 (01:00 PM) (at the age of 41-year-old) as dose 1, single for COVID-19 immunization. The patient medical history included 2 c-sections, wisdom teeth removed, allergic to sulfa (sulfonamide allergy), carrots, celery and cilantro (food allergy). The patient concomitant medications were not reported. The patient did not receive any other medications within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient had been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 10Apr2021 at 14:00 (02:00 PM), the patient experienced facial numbing and tingling, regular flu-like symptoms, extreme nausea, ongoing dizziness, weakness, fatigue, constant tinnitus, ongoing vertigo, headaches, constant sinus pressure, funny taste in mouth, urine smells different, heart palpitations, racing heartbeat and anxiety. The adverse event resulted in a visit to doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient underwent lab tests and procedures which included SARS-CoV-2 test (nasal swab) was tested negative on 25Apr2021. The patient received treatment for the reported events which included prednisone, furosemide, meclizine and vestibular PT (vestibular rehabilitation). The clinical outcome of the events facial numbing and tingling, regular flu-like symptoms, extreme nausea, ongoing dizziness, weakness, fatigue, constant tinnitus, ongoing vertigo, headaches, constant sinus pressure, funny taste in mouth, urine smells different, heart palpitations, racing heartbeat and anxiety were not recovered at the time of this report.   The lot number for the vaccine (BNT162B2) was not provided and will be requested during follow up.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hot flush, Hypoaesthesia, Nausea, Tinnitus
Clinical narrative: facial numbing; facial numbing and tingling; regular flu-like symptoms,; extreme nausea; ongoing dizziness; weakness; fatigue; constant tinnitus; ongoing vertigo; headaches; constant sinus pressure; funny taste in mouth,; urine smells different; heart palpitations; racing heart beat; anxiety; This is a spontaneous report from a contactable consumer (patient). A 41-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for Injection, Lot number: unknown) via an unspecified route of administration, administered in arm left on 04Apr2021 at 13:00 (01:00 PM) (at the age of 41-year-old) as dose 1, single for COVID-19 immunization. The patient medical history included 2 c-sections, wisdom teeth removed, allergic to sulfa (sulfonamide allergy), carrots, celery and cilantro (food allergy). The patient concomitant medications were not reported. The patient did not receive any other medications within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient had been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 10Apr2021 at 14:00 (02:00 PM), the patient experienced facial numbing and tingling, regular flu-like symptoms, extreme nausea, ongoing dizziness, weakness, fatigue, constant tinnitus, ongoing vertigo, headaches, constant sinus pressure, funny taste in mouth, urine smells different, heart palpitations, racing heartbeat and anxiety. The adverse event resulted in a visit to doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient underwent lab tests and procedures which included SARS-CoV-2 test (nasal swab) was tested negative on 25Apr2021. The patient received treatment for the reported events which included prednisone, furosemide, meclizine and vestibular PT (vestibular rehabilitation). The clinical outcome of the events facial numbing and tingling, regular flu-like symptoms, extreme nausea, ongoing dizziness, weakness, fatigue, constant tinnitus, ongoing vertigo, headaches, constant sinus pressure, funny taste in mouth, urine smells different, heart palpitations, racing heartbeat and anxiety were not recovered at the time of this report.   The lot number for the vaccine (BNT162B2) was not provided and will be requested during follow up.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Asthenia, Dizziness, Fatigue, Headache
Clinical narrative: facial numbing; facial numbing and tingling; regular flu-like symptoms,; extreme nausea; ongoing dizziness; weakness; fatigue; constant tinnitus; ongoing vertigo; headaches; constant sinus pressure; funny taste in mouth,; urine smells different; heart palpitations; racing heart beat; anxiety; This is a spontaneous report from a contactable consumer (patient). A 41-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for Injection, Lot number: unknown) via an unspecified route of administration, administered in arm left on 04Apr2021 at 13:00 (01:00 PM) (at the age of 41-year-old) as dose 1, single for COVID-19 immunization. The patient medical history included 2 c-sections, wisdom teeth removed, allergic to sulfa (sulfonamide allergy), carrots, celery and cilantro (food allergy). The patient concomitant medications were not reported. The patient did not receive any other medications within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient had been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 10Apr2021 at 14:00 (02:00 PM), the patient experienced facial numbing and tingling, regular flu-like symptoms, extreme nausea, ongoing dizziness, weakness, fatigue, constant tinnitus, ongoing vertigo, headaches, constant sinus pressure, funny taste in mouth, urine smells different, heart palpitations, racing heartbeat and anxiety. The adverse event resulted in a visit to doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient underwent lab tests and procedures which included SARS-CoV-2 test (nasal swab) was tested negative on 25Apr2021. The patient received treatment for the reported events which included prednisone, furosemide, meclizine and vestibular PT (vestibular rehabilitation). The clinical outcome of the events facial numbing and tingling, regular flu-like symptoms, extreme nausea, ongoing dizziness, weakness, fatigue, constant tinnitus, ongoing vertigo, headaches, constant sinus pressure, funny taste in mouth, urine smells different, heart palpitations, racing heartbeat and anxiety were not recovered at the time of this report.   The lot number for the vaccine (BNT162B2) was not provided and will be requested during follow up.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Influenza like illness, Nausea, Palpitations, Paraesthesia
Clinical narrative: facial numbing; facial numbing and tingling; regular flu-like symptoms,; extreme nausea; ongoing dizziness; weakness; fatigue; constant tinnitus; ongoing vertigo; headaches; constant sinus pressure; funny taste in mouth,; urine smells different; heart palpitations; racing heart beat; anxiety; This is a spontaneous report from a contactable consumer (patient). A 41-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for Injection, Lot number: unknown) via an unspecified route of administration, administered in arm left on 04Apr2021 at 13:00 (01:00 PM) (at the age of 41-year-old) as dose 1, single for COVID-19 immunization. The patient medical history included 2 c-sections, wisdom teeth removed, allergic to sulfa (sulfonamide allergy), carrots, celery and cilantro (food allergy). The patient concomitant medications were not reported. The patient did not receive any other medications within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient had been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 10Apr2021 at 14:00 (02:00 PM), the patient experienced facial numbing and tingling, regular flu-like symptoms, extreme nausea, ongoing dizziness, weakness, fatigue, constant tinnitus, ongoing vertigo, headaches, constant sinus pressure, funny taste in mouth, urine smells different, heart palpitations, racing heartbeat and anxiety. The adverse event resulted in a visit to doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient underwent lab tests and procedures which included SARS-CoV-2 test (nasal swab) was tested negative on 25Apr2021. The patient received treatment for the reported events which included prednisone, furosemide, meclizine and vestibular PT (vestibular rehabilitation). The clinical outcome of the events facial numbing and tingling, regular flu-like symptoms, extreme nausea, ongoing dizziness, weakness, fatigue, constant tinnitus, ongoing vertigo, headaches, constant sinus pressure, funny taste in mouth, urine smells different, heart palpitations, racing heartbeat and anxiety were not recovered at the time of this report.   The lot number for the vaccine (BNT162B2) was not provided and will be requested during follow up.